Ashwagandha vs Magnesium Glycinate: Which to Take?Magnesium glycinate vs ashwagandha: what the trials found, stress vs tension sleep trouble, safety, medicines and taking both. Find your fit.

Quick verdict

Pick by the problem, not the hype. On the evidence cited below:

• Stress keeps you up (work worry, a racing mind): ashwagandha root extract has the more direct trials. A meta-analysis of 5 trials found a small but significant effect on sleep (Cheah et al., 2021), and stressed adults had lower cortisol, though perceived-stress results are mixed (Albalawi, 2025).
• You're wired, sleep lightly or eat few magnesium-rich foods: magnesium glycinate. Its effect is small, and in one trial's exploratory analysis people with lower dietary magnesium seemed to gain most (Schuster et al., 2025).
• You have a thyroid, liver or autoimmune condition, are pregnant or breastfeeding, or have surgery coming up: skip ashwagandha (NCCIH; BfR, 2024).
• You have kidney disease: don't start magnesium without your doctor (Yeom & Cho, 2024).
• Poor sleep for months, loud snoring or gasping at night: see a doctor before either.

Stress or tension? Name the problem first.

How they differ

Ashwagandha is a plant extract thought to act on the body's stress system. Magnesium is an essential mineral involved in the brain's calming signals. One is optional; the other you need every day, from food first.

Ashwagandha: a root extract

Ashwagandha (Withania somnifera) is an Ayurvedic herb. Supplements use the root, or sometimes root and leaf, and quality extracts are standardised to compounds called withanolides. KSM-66, for example, is a root-only extract standardised to at least 5% withanolides (Chandrasekhar et al., 2012). In one trial in stressed adults, an extract lowered morning cortisol and DHEA-S compared with placebo, which the authors read as a sign that it works through the hypothalamus-pituitary-adrenal (stress-hormone) axis (Lopresti et al., 2019).

Magnesium glycinate: a mineral, bound to glycine

Magnesium glycinate (or bisglycinate) is magnesium bound to the amino acid glycine. Magnesium is involved in GABA, the brain's main calming messenger, and in the stress-hormone axis, but much of that comes from mechanism, not sleep trials (Yeom & Cho, 2024). Read labels for the elemental figure, not the powder weight. A worked example from a pack we can check: SILT Nights prints "Magnesium Bisglycinate (13.8% elemental)" at 1.8 g, and 1.8 g × 0.138 is about 0.248 g, which the pack states as 250 mg magnesium (SILT pack). By the same sum, a front label that says "2,000 mg magnesium glycinate" hasn't told you the dose until it gives the elemental percentage; at the same 13.8%, 2,000 mg of powder would be about 276 mg of magnesium. India's RDA is 440 mg a day for adult men and 370 mg for adult women, and food counts towards it (ICMR-NIN, 2020).

What the trials show

Both have small trials and small effects. Ashwagandha's trials are closer to the "stressed and sleeping badly" question; magnesium's are mostly about sleep alone. Most ashwagandha trials ran for 8-10 weeks, many were done in India, and several used extract supplied or funded by its maker, which we note for each.

Ashwagandha: stress and stress-linked sleep

• Sleep, pooled. A meta-analysis of 5 randomised trials (400 adults) found a small but significant effect on overall sleep. The effect was larger in people diagnosed with insomnia, at 600 mg a day or more, and over 8 weeks or longer. Data on serious side effects were limited. The authors declared no competing interests (Cheah et al., 2021). A 2024 meta-analysis of 5 trials (254 people with anxiety, insomnia or both) found improvements in time to fall asleep, total sleep time, sleep efficiency and PSQI scores, and asked for larger trials (Fatima et al., 2024).
• Insomnia with anxiety (India). 60 adults took 300 mg of KSM-66 twice a day, or a placebo, for 10 weeks. By actigraphy, they took 29.0 minutes to fall asleep vs 33.9 on placebo, and sleep efficiency improved. The extract maker supplied the extract; the authors declared no competing interests (Langade et al., 2019).
• Stressed adults (India). 60 adults with Perceived Stress Scale scores above 20 took 250 mg or 600 mg a day, or a placebo, for 8 weeks. Perceived stress and serum cortisol fell at both doses, and sleep quality improved compared with placebo. KSM-66's maker gifted the extract (Salve et al., 2019).
• A different extract. 60 stressed adults took 240 mg of Shoden a day for 60 days. Scores on the Hamilton anxiety scale fell more than on placebo, a broader distress scale (DASS-21) didn't differ significantly, and morning cortisol fell. Shoden's maker funded the study (Lopresti et al., 2019).
• The caveat. A 2025 meta-analysis (488 participants) found cortisol fell by about 1.16 µg/dL across 7 studies, but perceived stress didn't change significantly across 6 (Albalawi, 2025). A 2026 dose-response meta-analysis of 22 trials reported better stress, anxiety and depression scores, and still called for higher-quality trials to settle doses and durations (Alsanie et al., 2026). Both declared no competing interests.

Magnesium glycinate: small, inconsistent effects

• Adults reporting poor sleep. In a 2025 double-blind trial, 155 adults aged 18-65 took 250 mg elemental magnesium as bisglycinate, or a placebo, daily. After 4 weeks, Insomnia Severity Index scores fell by 3.9 points vs 2.3 on placebo, a small effect (d = 0.2), with no difference in other psychological outcomes. One co-author runs a contract research organisation that receives funding from nutraceutical companies (Schuster et al., 2025).
• Older adults with insomnia. A meta-analysis of 3 trials (151 people) found they fell asleep 17 minutes faster than on placebo; total sleep time didn't change significantly, and the evidence was low to very low quality (Mah & Pitre, 2021).
• The newest review. A 2026 systematic review of 12 trials found inconsistent results and low to very low certainty, and concluded the evidence doesn't support magnesium as a routine insomnia treatment, though it may modestly help some self-reported outcomes (Lopresti et al., 2026). Its lead author is the co-author above who runs the contract research organisation; we couldn't access the review's own funding statement.
• Stress and anxiety. A review of 18 studies found the evidence "suggestive" of a benefit on self-rated anxiety in already-vulnerable groups, but of poor quality, and no study used a validated stress measure. One author sat on a drug company's consumer-health advisory board (Boyle et al., 2017).

What the clinical guideline says

A 2022 international taskforce of 31 clinicians and researchers rated ashwagandha "provisionally recommended" for anxiety disorders, as an add-on within standard medical care. It found no nutraceutical, magnesium included, with enough evidence for any anxiety-related disorder, apart from N-acetylcysteine for OCD-related disorders (Sarris et al., 2022). That's a judgement about diagnosed conditions and doctors' practice, not a reason to self-treat.

Stress-driven or tension-driven?

"Stress-driven" and "tension-driven" are our plain-language labels, not diagnoses. Stress-driven means your mind won't switch off: work replays, worry, tired but wired. Tension-driven means your body won't settle: restless, sleeping lightly, waking often. Match the option to the pattern, and see a doctor if it's been going on for months.

If you're weighing other options too, such as melatonin, glycine or L-theanine, our best sleep supplements in India guide compares them.

Can you take ashwagandha and magnesium together?

None of the sources we checked lists ashwagandha and magnesium as interacting with each other. But no trial shows the pair works better than either one alone.

We searched PubMed on 8 October 2026 for trials of ashwagandha (or Withania somnifera) with magnesium and found one randomised trial that gave both. 103 physically active adults took, for 2 weeks, a morning capsule (600 mg ashwagandha + 300 mg rhodiola), an evening capsule (magnesium L-threonate supplying 145 mg magnesium + 200 mg L-theanine + 50 mg apigenin), both, or placebos. The morning-only group improved on weekly perceived stress and some sleep measures, and its subjective sleep quality was better than the group taking both (Mastrofini et al., 2026). It used a different magnesium form, mixed several ingredients and ran briefly, so it can't tell you what ashwagandha plus magnesium glycinate does. We couldn't access its funding statement.

So treat it as two decisions. If you combine them, every caution for each one still applies, and ashwagandha's are the stricter set.

Head-to-head table

Ashwagandha vs magnesium glycinate on one screen. "Evidence" is our editorial summary of the sources on this page, not a clinical grade.

SILT Nights: both, plus two more

If you want only one of these, buy that one: our magnesium glycinate powder and ashwagandha supplement guides show what to look for. SILT Nights is for people who want both in one melatonin-free drink at bedtime, and who have checked the ashwagandha cautions above.

Each stick has 1.8 g magnesium bisglycinate (250 mg elemental magnesium, about 57% of the men's RDA and 68% of the women's), 300 mg KSM-66® ashwagandha root extract, 3 g glycine and 200 mg L-theanine; every dose is printed on the back of the pack. No melatonin, no caffeine, no maltodextrin and no added sugar; Chamomile Lemon is the flavour, not a dosed active. The rest of the ingredient list is taste and processing ingredients, none of them actives: citric and malic acid, cumin powder, black salt, iodised salt, silicon dioxide as an anti-caking agent and steviol glycosides (SILT pack). Directions on the pack: 1 stick per day, not to exceed the recommended usage level, stirred into 200-250 ml of lukewarm or cold water; do not use boiling water, because heat degrades sensitive actives. Drinking it 30-60 minutes before bed is the window we recommend, not a pack direction. The magnesium form and elemental dose are the ones in the 2025 trial, and KSM-66 is one of the extracts studied above, but no trial has tested this drink or this combination, and we don't claim a stick reproduces any trial's results.

Because it contains ashwagandha, everything in the safety section applies to SILT Nights too. It's a food supplement, not a medicine: if you have a liver or thyroid condition, are pregnant, or take regular medicines, check with your doctor first. Every ingredient has a supplier certificate of analysis (13 ingredients, 198 checks, none failed); the KSM-66 certificate lists the plant part as roots and shows 5.3% withanolides against a 5% minimum, and the glycine certificate shows 99.4% purity to a USP pharma-grade standard. The pack's own caution: not for medicinal use, not intended to treat, cure or prevent any disease, not a substitute for a varied diet; if you're pregnant or nursing, taking any medications or have any medical conditions, contact your healthcare practitioner. The finished-drink NABL lab test is pending, and we'll publish it when it's ready. See the formula and certificates on our science page. SILT is FSSAI compliant (FSSAI Lic. No. 12826999000631), vegetarian and made in India, and the stick is made by I Dreamz Health Care in Harohalli, Karnataka (FSSAI Lic. No. 11216325000322).

MRP ₹1,125 ₹900 · 15 sticks or ₹1,500 for 30 (MRP ₹2,250)

That's ₹60 a stick on the 15-pack, or ₹50 a stick on the 30-pack.

So, ashwagandha or magnesium glycinate?

If stress is what keeps you up, ashwagandha root extract has the more relevant trials, but only if none of its cautions apply to you. If your body won't settle, or your diet is light on magnesium, magnesium glycinate is the lower-risk place to start, with modest expectations. If you want both in one bedtime drink, that's what we built SILT Nights for. Our ashwagandha supplement and magnesium glycinate powder guides go deeper on each. Evidence, not hype.

MRP ₹1,125 ₹900 · 15 sticks or ₹1,500 for 30 (MRP ₹2,250)